tirzepatide approval in canada Clinical trial on GLP-1RA (tirzepatide) to begin Health Canada approves Mounjaro® (tirzepatide)

With less room (and desire) to eat, every bite becomes essential

The chart below shows the kind of results seen in major clinical trials, which helps put the efficacy of these medications into perspective

It is the low and slow approach to weight loss

Retatrutide (10mg / 30mg) Lyophilized Powder - Research Use Only The adverse event profile was consistent with expectations for incretin-based therapies, with gastrointestinal symptoms being the most frequently reported side effects across all dose levels

Because IGF-1 signalling promotes cell proliferation, a recognized theoretical concern is that it could promote the growth of existing tumors , and excess dosing can cause hypoglycemia